Clinical presentation, complications and treatment of infection with verocytotoxin-producing Escherichia coli. Challenges for the clinician

Journal of Applied Microbiology Symposium Supplement

Volumn 88, Issue 29, 2000, Pages

  Dundas, S ^a   Todd, W T A ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; PHOSPHOENOLPYRUVATE; VEROTOXIN;

ABDOMINAL PAIN; AGE; CLINICAL TRIAL; DIARRHEA; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; FECES ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IRRITABLE COLON; JAPAN; KIDNEY FAILURE; LEUKOCYTE COUNT; PROGNOSIS; REVIEW; RISK FACTOR; STOMACH MOTILITY; UNITED KINGDOM;

ENTEROBACTER; ESCHERICHIA COLI; PURPURA;

EID: 0034128388     PISSN: 02674440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Ahmed, S. and Donaghy, M. (1998) An outbreak of Escherichia coli O157:H7 in Central Scotland. In Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains ed. Kaper, J.B. and O'Brien, A.D. pp. 59-65. Washington, D.C.: ASM Press.
2. Bell, B.P., Griffin, P.M., Lozano, P., Christie, D.L., Kobayashi, J.M. and Tarr, P.I. (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100, e12.
3. Belongia, E.A., Osterholm, M.T., Soler, J.T., Ammend, D.A., Braun, J.E. and MacDonald, K.L. (1993) Transmission of Escherichia coli O157:H7 in Minnesota child day-care facilities. Journal of the American Medical Association 269, 883-888.
4. Carter, A.O., Borczyk, A.A., Carlson, J.A.C., Harvey, B., Hockin, J.C. and Karmali, M.A. (1987) A severe outbreak of Escherichia coli O157:H7 - Associated haemorrhagic colitis in a nursing home. New England Journal of Medicine 24, 1496-1500.
5. Cimolai, N., Carter, J.E., Morrison, B.J. and Anderson, J.D. (1990) Risk factors for the progression of Escherichia coli O157:H7 enteritis to the hemolytic-uraemic syndrome. Journal of Pediatrics 116, 589-592.
6. Drummond, K. (1985) Haemolytic uraemic syndrome - then and now. New England Journal of Medicine 312, 116-118.
7. Dundas, S., Murphy, J., Soutar, R.L., Jones, G.A., Hutchinson, S.J. and Todd, W.T.A. (1999a) Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak. Lancet 354, 1327-1330.
8. Dundas, S., Todd, W.T.A., Stewart, A.I., Chaudhuri, A.K.R. and Murdoch, P.S. (1999b) The central Scotland 1996 Escherichia coli O157 outbreak. Predictors of hemolytic uraemic syndrome/thrombotic thrombocytopenic purpura and death (in press).
9. Farthing, M., Feldman, R., Finch, R. et al. (1996) The management of infective gastroenteritis in adults. A consensus statement by an expert panel convened by the British Society for the Study of Infection. Journal of Infection 33, 143-152.
10. Fitzpatrick, M., Shah, V., Trompeter, R. and Dhillon, M. (1991) Long term outcome after childhood haemolytic uraemic syndrome. British Medical Journal 303, 489-492.
11. Griffin, P.M. (1995) Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In Infections of the Gastrointestinal Tract ed. Blaser, M.J., Smith, P.D., Ravdin, J.I., Greenberg, H.B. and Guerrant, R.L. pp. 739-761. New York: Raven Press.
12. Griffin, P.M., Olmstead, L.C. and Petras, R.E. (1990) Escherichia coli O157:H7-assosciated colitis. Gastroenterology 99, 142-149.
13. Griffin, P.M., Ostroff, S.M., Tauxe, R.V., Greene, K.D., Wells, J.G. and Blake, P.A. (1988) Illnesses associated with Escherichia coli O157:H7 infections. Annals of Internal Medicine 109, 705-712.
14. Hertzke, D.M., Cowan, L.A., Schonong, P. and Fenwick, B.W. (1995) Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Veterinary Pathology 32, 451-459.
15. Karch, H., Janetzki-Mittmaann, C., Aleksic, S. and Datz, M. (1996) Isolation of enterohaemorrhagic Escherichia coli O157 strains from patients with haemolytic-uraemic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. Journal of Clinical Microbiology 34, 516-519.
16. Lissner, R., Schmidit, H. and Karch, H. (1996) A standard immunoglobulin press produced from bovine colostra shows antibody reactivity and neutralising activity against Shiga-like toxins and EHEC hemolysin of Escherichia coli O157:H7. Infection 24, 378-383.
17. Martin, D.L., MacDonald, K.L., White, K.E., Soler, J.T. and Osterholm, M.T. (1990) The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. New England Journal of Medicine 323, 1161-1167.
18. Mead, P.S. and Griffin, P.M. (1998) Escherichia coli O157:H7. Lancet 352, 1207-1212.
19. Morris, K.P., Coulthard, M.G. and Rangecroft, L. (1991) Oesophageal and severe gut involvement in the haemolytic uraemic syndrome. British Journal of Surgery 78, 1469-1472.
20. National Institute of Health and Infectious Disease (1997) Verocytotoxin producing Escherichia coli (enterohemorrhagic E. coli) infections, Japan 1996-June 1997. Infectious Agents Surveillance Report 18, 153-154.
21. Parry, S.M., Salmon, R.L., Willshaw, G.A. and Cheasty, T. (1998) Risk factors for and prevention of sporadic infections with verocytotoxin (shiga toxin) producing Escherichia coli O157. Lancet 351, 1019-1022.
22. Pavia, A.T., Nichols, C.R. and Green, D.P. (1990) Haemolytic uraemic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and cpidemiological observations. Journal of Pediatrics 116, 544-551.
23. Proulx, F., Turgoen, J.P., Delage, G., Lafleur, L. and Chicoine, L. (1992) Randomised controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. Journal of Pediatrics 121, 299-303.
24. Reilly, W.J. (1997) E. coli O157 in Scotland - an overview. Scottish Centre for Infection and Environmental Health Weekly Report (Suppl. 1, 97/13), 4-5.
25. Seigler, R.L. (1995) The hemolytic uremic syndrome. Pediatric Clinics of North America 42, 1505-1529.
26. Shah, S., Hoffman, R., Shillmam, P. and Wilson, B. (1996) Prolonged faecal shedding of Escherichia coli O157:H7 during an outbreak in a day care centre. Clinical Infectious Diseases 23, 835-836.
27. Slutsker, L., Ries, A.A., Greene, K.D., Wells, J.G., Hutwagner, L. and Griffin, P.M. (1997) Escherichia coli O157:117 diarrhoea in the United States: Clinical and epidemiological features. Annals of Internal Medicine 126, 505-513.
28. Takeda, T., Yoshino, K., Uchida, H., Ikeda, N. and Tanimura, M. (1998) Early use of fosfomycin for Shiga toxin-producing Escherichia coli O157 infection reduces the risk of hemolytic uremic syndrome. In Escherichia coli O157: H7 and Other Shiga-Toxin Producing E. coli Strains ed. Kaper, J.B. and O'Brien, A.D. pp. 385-387. Washington, D.C.: ASM Press.
29. Tarr, P.I., Neill, M.A., Clausen, C.R., Watkins, S.L., Christie, D.L. and Hickman, R.O. (1990) Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early culture in establishing the etiology. Journal of Infectious Diseases 162, 553-556.
30. Tilden, J. Jr, Young, W., McNamara, A.M. et al. (1996) A new route of transmission for Escherichia coli: infection from dry fermented salami. American Journal of Public Health 861, 1142-1145.
31. Van der Kar, N.C.A.L., Monnens, L.A.H., Karmali, M.A. and van Hinsgergh, V.W.M. (1992) Tumour necrosis factor and interlcukin-I induce expression of the verocytotoxin receptor globtriaosylceramide on human endothelial cells. Blood 80, 2755-2764.
32. Walters, M.S., Matthei, I.U., Kay, R. and Dhillon, M.J. (1989) The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatric Nephrology 3, 130-134.
33. Yoh, M., Frimpong, E.K., Voravuthikunchai, S.R. and Honda, T. (1999) Effects of subinhibitory concentrations of antimicrobial agents (quinolones and macrolides) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. Canadian Journal of Microbiology. 45, 732-739.